Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-05-003166
Filing Date
2005-09-08
Accepted
2005-09-08 15:44:14
Documents
2
Period of Report
2005-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 6189
2 classon.htm EX-24 6893
  Complete submission text file 0001005477-05-003166.txt   15186
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 KINGSBRIDGE RD PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE RD C/O ENZON INC PISCATAWAY NJ 08854 9089804500
CLASSON ROLF A (Reporting) CIK: 0001030325 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 051075308